Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Asset Writedowns and Impairment (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Asset Writedowns and Impairment for 9 consecutive years, with $65000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $65000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $257000.0, a 22.82% decrease, with the full-year FY2024 number at $77000.0, down 90.14% from a year prior.
  • Asset Writedowns and Impairment was $65000.0 for Q3 2025 at SANUWAVE Health, down from $98000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $234000.0 in Q3 2023 to a low of -$48000.0 in Q2 2024.
  • A 3-year average of $113700.0 and a median of $122500.0 in 2024 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: plummeted 130.57% in 2024, then skyrocketed 304.17% in 2025.
  • SANUWAVE Health's Asset Writedowns and Impairment stood at $234000.0 in 2023, then tumbled by 73.93% to $61000.0 in 2024, then grew by 6.56% to $65000.0 in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Asset Writedowns and Impairment are $65000.0 (Q3 2025), $98000.0 (Q2 2025), and $33000.0 (Q1 2025).